Navigation Links
Warner Chilcott Completes Acquisition of P&G's Global Branded Prescription Pharmaceuticals Business
Date:10/30/2009

ity or the delayed-draw term loan facility. The Company's existing $380 million aggregate principal amount of 8 3/4% senior subordinated notes remain outstanding.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the U.S. and Western European pharmaceuticals market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G

SOURCE Warner Chilcott plc


'/>"/>
SOURCE Warner Chilcott plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent
2. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
9. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
10. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
11. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- LumiThera Inc., a developmental stage medical device company ... disorders and disease, announced today that they were ... Life Sciences Discovery Fund (LSDF) commercialization grant. LumiThera was ... grants worth $500,000 to provide for commercialization activities ... macular degeneration (AMD). LSDF executive ...
(Date:5/27/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/nt9zlx/asia_pacific ) has announced the ... Growth, Trends And Forecasts (2014 - 2019)" company ... detailed type of imaging that customs a low-dose x-ray ... mammogram, is used to support in the early detection ... (radiograph) is a noninvasive medical test that helps physicians ...
(Date:5/27/2015)... 2015 The report " Tube Packaging Market ... Oral Care, Food & beverages, Pharmaceuticals, Consumer Goods), by Material ... - Trends & Forecasts to 2020", published by MarketsandMarkets, The ... a CAGR of 6.65% from 2015, to reach $8,638.9 Million ... Tables and   61 F igures spread thro ...
Breaking Medicine Technology:LumiThera Receives LSDF Commercialization Grant Award 2Asia Pacific Mammography Market Trends and Forecasts 2015-2019 2Tube Packaging Market Worth $8.63 Billion by 2020 2Tube Packaging Market Worth $8.63 Billion by 2020 3Tube Packaging Market Worth $8.63 Billion by 2020 4
... IRVINE, Calif., Feb. 22, 2011 ResearchDx announced ... Diagnostics Organization or CDO. Recent ... and the Drug-Diagnostic Co-Development Concept Paper, have spurred ... purpose of developing companion diagnostics. The traditional Contract ...
... Enox Biopharma, Inc. CEO, John C. Rewcastle, Ph.D., will present ... February 24 at 11:05 AM PST. The conference is being ... Dr. Rewcastle will provide an overview of Enox,s technology ... devices rendering them antimicrobial. He will also review recently published ...
Cached Medicine Technology:ResearchDx Launches Contract Diagnostics Organization (CDO) 2Enox Biopharma, Inc. to Present at IN3 West Investment in Innovation Conference. 2
(Date:5/27/2015)... In today's healthcare landscape, where costs ... be challenging for doctors and hospitals to keep up ... , Austin-based HealthTronics, Inc. is offering a ... therapies for clinically sophisticated applications. The company has now ... Laser Ventures, Inc ., a mobile laser technology ...
(Date:5/27/2015)... 2015 Dr. Omar Ibrahimi, Dermatologist and ... CT has been selected as part of a controlled ... (and the only physician in Connecticut) to offer the ... the removal of submental fat (double chin). The procedure ... no surgery and minimal risks. Dr. Ibrahimi is an ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a ... organizations, announced today that SanMar Corporation successfully implemented ... attendance and point tracking processes for over 3,000 ... , Family-owned since 1971, Seattle-based SanMar Corporation ... label, and mill brands. SanMar supplies apparel and ...
(Date:5/27/2015)... 2015 In support of a ... of the Journal of American Geriatrics Society about the ... Bedford Commons OB-GYN P.A . is reiterating the ... beverages. , To examine the relationship between diet ... Antonio Longitudinal Study of Aging (SALSA) tracked the soda ...
(Date:5/27/2015)... 2015 The Case Management Society ... to provide CMSA's Career and Knowledge Pathways educational ... to strengthen the case/care management workforce by offering ... The mutually beneficial agreement provides Medix, a workforce ... talent in the healthcare, scientific and IT industries, ...
Breaking Medicine News(10 mins):Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3
... Luminex Corporation,(Nasdaq: LMNX ) today announced that ... to be held September 24-27, 2007, in New,York City. ... and chief,executive officer, and Harriss T. Currie, chief financial ... September 24, 2007. The,presentation will be webcast live and ...
... BEDFORD, Mass., Sept. 19 Hologic, Inc.,(Nasdaq: HOLX ... be presenting at the UBS Global Life Sciences Conference ... Hyatt Hotel in New York, NY. Interested parties ... of,Hologic,s investor presentation on Wednesday, September 26, 2007 at ...
... Sept. 19 Statement by Chris,Cathcart, President, CSPA: ... the report issued by the Natural Resources,Defense Council ... of air,freshener products. NRDC,s report appears to be ... unit each of 14 air freshener products. As ...
... of parents feel they play a significant role in ... at the University of Michigan C.S. Mott Childrens Hospital. ... issue of the Journal of Pediatrics, 86 percent of ... their hospitalized childs medical care. Researchers also found that ...
... is one of four oral medications approved by ... the treatment of alcoholism. A recent large ... the National Institute of Alcoholism and Alcohol Abuse ... a modest but significant benefit but another FDA-approved ...
... (H 2 S) directly into the heart during a ... damage often seen in oxygen-starved organs, according to a ... at Birmingham. , H 2 S boosts post-heart-attack function ... effect of restoring blood flow swiftly to hearts suffering ...
Cached Medicine News:Health News:Luminex Corporation To Present at UBS Global Life Sciences Conference 2Health News:Consumer Specialty Products Association Highly Critical of NRDC Study on Home Air Fresheners 2Health News:Parents' participation in medical decisions linked to self-efficacy 2Health News:Family history of alcoholism affects response to drug used to treat heavy drinking 2Health News:Severe heart attack damage limited by hydrogen sulfide 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: